Cite
Cardiac Effects of Siponimod (BAF312) Re-initiation After Variable Periods of Drug Discontinuation in Healthy Subjects.
MLA
Legangneux, Eric, et al. “Cardiac Effects of Siponimod (BAF312) Re-Initiation After Variable Periods of Drug Discontinuation in Healthy Subjects.” Clinical Therapeutics, vol. 38, no. 3, Mar. 2016, p. 631. EBSCOhost, https://doi.org/10.1016/j.clinthera.2016.01.021.
APA
Legangneux, E., Shakeri-Nejad, K., Aslanis, V., Sagkriotis, A., Pezous, N., Brendani, B., Behrje, R., & Gutierrez, M. (2016). Cardiac Effects of Siponimod (BAF312) Re-initiation After Variable Periods of Drug Discontinuation in Healthy Subjects. Clinical Therapeutics, 38(3), 631. https://doi.org/10.1016/j.clinthera.2016.01.021
Chicago
Legangneux, Eric, Kasra Shakeri-Nejad, Vassilios Aslanis, Alexandros Sagkriotis, Nicole Pezous, Bruno Brendani, Rhett Behrje, and Maria Gutierrez. 2016. “Cardiac Effects of Siponimod (BAF312) Re-Initiation After Variable Periods of Drug Discontinuation in Healthy Subjects.” Clinical Therapeutics 38 (3): 631. doi:10.1016/j.clinthera.2016.01.021.